Our Technology Edge
Unlike traditional hearing aid manufacturers that rely on fixed-function chipsets, Sonotu has developed a proprietary technology platform that combines custom electronics, firmware, and AI-driven algorithms.
Built in collaboration with the University of Warwick, this platform enables greater flexibility, lower manufacturing costs, and a faster path to future innovation.
01
Proprietary chipset architecture
02
Custom firmware ecosystem
03
HeartuAI™ speech enhancement
04
Over-the-air software updates
05
Up to 50% lower bill of materials
06
AI-ready hardware platform
Why Our Platform Is Different?
Why us ?
Most hearing aid manufacturers are constrained by expensive, non-reconfigurable chipsets that limit the functionality they can deploy.
Sonotu's reconfigurable platform provides complete control over device performance, allowing rapid feature development, lower production costs, and future AI integration without dependence on third-party hardware vendors.
0%
0%
Lower hardware cost structure
0X
0X
AI power efficiency
0%
0%
Control over technology roadmap
Product Road Map.
Clinical-grade rechargeable hearing solution designed to establish regulatory credibility and validate market adoption.
01
OVVI1
Available Today, Clinical-grade rechargeable hearing solution designed to establish regulatory credibility and validate market adoption.
02
OVVI1+
Q4 2026, A more compact and intelligent device built on the same proven platform architecture.
03
Gen 2 AI Platform
Q3 2027, The next generation of Sonotu's hearing platform powered by advanced AI processing capabilities.
Got Questions?
Answers for clinicians, partners, and investors evaluating Sonotu’s hearing technology platform.
How does Sonotu’s hearing technology work?
Is the technology clinically validated?
What is Sonotu’s regulatory pathway?
Does Sonotu manufacture its own devices?
How can healthcare partners work with Sonotu?